Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. BioElectronics Corporation (BIEL) Message Board

Thanks BW, here is a translation for the no hablo

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 8393
(Total Views: 515)
Posted On: 04/04/2019 10:04:25 AM
Avatar
Posted By: swordfish
Re: Belgian Waffle #1292
Thanks BW, here is a translation for the no hablo español crowd

ActiPatch®, non-pharmacological treatment of pain, in Infarma 2019
March 27, 2019

Professional events such as the Encuentro Europeo de Farmacia Infarma, held last week in Barcelona, are a great opportunity to learn first-hand about the main novelties that are produced in the sector and that will bring favorable changes for the health of people.

AvanFarma, pharmacy division of Acuña and Fombona, one of the leading companies in the distribution of medical-surgical products in Spain and Portugal, wanted to be present at this meeting, an unmissable event for all professionals in the pharmaceutical sector. "This is the first year that AvanFarma, an Asturian brand that stands out for the solid experience of its staff, its firm commitment and for offering innovative solutions, participates in Infarma, and we are very excited," acknowledges Sergio López-Fombona, CEO of Acuña and Fombona.

AvanFarma brought the ActiPatch® portable therapeutic microdevice, very effective in the non-pharmacological treatment of pain, based on the technology of electromagnetic fields, which acts against the pain of muscles and joints and can be worn 24 hours a day. Despite advances in the field of pain management, millions of people continue to suffer from chronic pain, which is why research has been aimed at guaranteeing the analgesic and anti-inflammatory effect, without the need to provide drugs.

http://actipatch.es/tratamiento-no-farmacolog...arma-2019/

https://translate.google.com/translate?hl=en&...rev=search

https://www.avanfarma.com/es/


(1)
(0)




BioElectronics Corporation (BIEL) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us